SMS Pharmaceuticals Share Price

SMS Pharmaceuticals Share Price

NSE: SMSPHARMA
|
Pharmaceuticals

₹ 438.30

-₹3.10 (-0.7%)
1D
Last updated 13 Oct, 2026, 15:51 IST

SMS Pharmaceuticals Share Price Today

As of 14 Oct 2026, SMS Pharmaceuticals share price is ₹438.30. The stock opened at ₹444.00, compared to its previous close of ₹441.40. During today's trading session, SMS Pharmaceuticals share price moved in the range of ₹426.05 to ₹444.00, with an average price of ₹435.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹270.10 and a high of ₹494.45. On the performance front, SMS Pharmaceuticals share price has increased by 5.15% over the last six months and is up 56.45% on a year-on-year basis.

₹426.05
0.70% down today
₹444.00
1D LOW
1D HIGH

SMS Pharmaceuticals Returns Calculator

Volume
3,86,275
Average traded price
₹433.22
Last traded time
03:51:09 13 Oct
Last traded quantity
25
Circuit
L
H
₹353.15
₹529.65
52-week
L
H
₹270.10
₹494.45
Mkt Cap Cr
4,131.46
P/E
40.36
P/B
5.26
ROA
6.57%
ROE
12.98%
ROCE
12.14%
EV/EBITDA
24.58
Based on fundamentals, this stock's
Step 2 of 5
Performance
Poor
SMS Pharma. has underperformed the market
Step 1 of 5
Valuation
Overvalued
SMS Pharma. appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
SMS Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%21.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%56.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%38.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%14.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%53.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%17.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%15.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%25.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%12.47
Lupin89,628.8316.033.9614.47%23.76%24.88%9.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About SMS Pharmaceuticals

SMS Pharmaceuticals Share Price
ISIN
INE812G01025
Sector Market Cap
₹ 4,131.46 Cr

SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.

SMS Pharmaceuticals Financial Highlights

  • Revenue: SMS Pharmaceuticals reported revenue of ₹895.22 crore in FY26 vs ₹788.97 crore in FY25. It showed an increase of 13.47% on a yearly basis.
  • Operating Profit: SMS Pharmaceuticals reported an operating profit of ₹116.64 crore in FY26 vs ₹92.34 crore in FY25. It showed an increase of 26.32% on a year-on-year basis.
  • Net Profit: SMS Pharmaceuticals reported a net profit of ₹88.00 crore in FY26 vs ₹67.40 crore in FY25. It showed an increase of 30.56% on a yearly basis.

SMS Pharmaceuticals Quarterly Result Highlights

  • SMS Pharmaceuticals reported revenue of ₹208.70 crore in Jun 2026, compared with ₹240.52 crore in Mar 2026, representing a decrease of 13.23% on a quarter-on-quarter (QoQ) basis.
  • SMS Pharmaceuticals reported an operating profit of ₹27.21 crore in Jun 2026, compared with ₹27.07 crore in Mar 2026, representing an increase of 0.52% on a quarter-on-quarter (QoQ) basis.
  • SMS Pharmaceuticals reported a profit of ₹20.20 crore in Jun 2026, compared with ₹20.96 crore in Mar 2026, reflecting a decrease of 3.63% on a QoQ basis.
  • The earnings per share (EPS) of SMS Pharmaceuticals stood at ₹8.16 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
68.07%
FII
1.18%
Other DII
0.19%
Retail and other
30.56%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.04%
Mar 20260.31%
Jun 20260.65%
Sep 20261.18%
1 day
-0.70%
1 week
-7.18%
1 month
-5.43%
1 year
+56.45%
3 years
+261.34%
5 years
+189.98%
Day
Open / Close
Change %
13 Oct 26
₹444.00 / ₹438.30
-0.70%
12 Oct 26
₹446.80 / ₹441.40
-0.73%
09 Oct 26
₹448.05 / ₹444.65
-0.47%
08 Oct 26
₹472.00 / ₹446.75
-4.71%
Show more

SMS Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹782.75₹709.26₹522.05₹519.87
Other Income₹6.22₹4.46₹4.91₹5.20
Total Revenue₹788.97₹713.72₹526.97₹525.07
Total Expenses₹696.64₹647.62₹521.62₹456.57
Profit Before Tax₹92.34₹66.11₹5.35₹68.50
Tax₹24.94₹16.91₹1.47₹0.62
Profit After Tax₹67.40₹49.20₹3.88₹67.88
EPS - Basic₹8.16₹5.89-₹0.83₹7.35
EPS - Diluted₹8.16₹5.89-₹0.83₹7.35

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹92.34₹66.11₹5.35₹68.50
Income before WC changes₹144.62₹120.07₹58.34₹118.36
Change in Assets-₹13.39-₹106.90-₹72.70-₹60.34
Change in Liabilities-₹29.69₹52.35₹41.41₹1.96
Change in WC-₹43.08-₹54.55-₹31.29-₹58.38
Cash flow from Operations₹81.71₹50.12₹22.45₹45.06
Cash flow from Investing-₹123.43-₹52.07-₹29.76-₹27.15
Cash flow from Financing₹47.08₹30.68-₹31.97-₹11.75
Total Cash Flow₹5.36₹28.73-₹39.28₹6.16
Cash (Start of the year)₹36.04₹7.31₹46.58₹40.42
Cash (End of the year)₹41.40₹36.04₹7.31₹46.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹598.21₹500.20₹468.96₹482.45
Current Assets₹554.47₹533.89₹410.65₹377.05
Total Assets₹1,152.68₹1,034.09₹879.61₹859.50
Current Liabilities₹324.37₹331.72₹254.91₹196.48
Net Current Asset₹230.10₹202.18₹155.74₹180.57
Non-Current Liabilities₹188.67₹166.05₹164.17₹192.73
Equity Capital₹639.64₹536.33₹460.53₹470.29
Total Equity & Liabilities₹1,152.68₹1,034.09₹879.61₹859.50

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹782.75₹709.26₹522.05₹519.87
Other Income₹6.22₹4.46₹4.91₹5.20
Total Revenue₹788.97₹713.72₹526.97₹525.07
Total Expenses₹695.65₹647.39₹521.42₹456.42
Profit Before Tax₹93.32₹66.33₹5.55₹68.65
Tax₹24.94₹16.91₹1.47₹0.62
Profit After Tax₹68.38₹49.42₹4.08₹68.04
EPS - Basic₹8.07₹5.84₹0.48₹8.04
EPS - Diluted₹8.07₹5.84₹0.48₹8.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹93.32₹66.33₹5.55₹68.65
Income before WC changes₹144.63₹120.07₹58.34₹118.36
Change in Assets-₹13.39-₹106.90-₹72.70-₹60.34
Change in Liabilities-₹29.69₹52.35₹41.41₹1.96
Change in WC-₹43.08-₹54.55-₹31.29-₹58.38
Cash flow from Operations₹81.71₹50.12₹22.45₹45.06
Cash flow from Investing-₹123.44-₹52.07-₹29.76-₹27.15
Cash flow from Financing₹47.08₹30.68-₹31.97-₹11.75
Total Cash Flow₹5.35₹28.73-₹39.28₹6.16
Cash (Start of the year)₹36.04₹7.31₹46.58₹40.42
Cash (End of the year)₹41.39₹36.04₹7.31₹46.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹631.64₹534.36₹503.54₹505.92
Current Assets₹554.46₹533.89₹410.65₹377.05
Total Assets₹1,186.10₹1,068.25₹914.18₹882.97
Current Liabilities₹324.36₹331.72₹254.91₹196.48
Net Current Asset₹230.10₹202.18₹155.74₹180.57
Non-Current Liabilities₹188.67₹166.05₹164.17₹192.73
Equity Capital₹673.07₹570.49₹495.10₹493.76
Total Equity & Liabilities₹1,186.10₹1,068.25₹914.18₹882.97
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
438.3
3
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 3
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.91
Neutral
ATR (14)
18.93
Neutral
STOCH(9,6)
10.94
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
36.59
Bearish
UO(9)
37.32
Neutral
ROC(12)
-8.6
Bearish
WillR(14)
-90.07
Bullish
Period
Simple value
Exponential vaue
5D
454.77
451.98
10D
464.11
457.01
20D
457.81
449.38
50D
405.57
423.24
100D
396.22
404.86
Volume trend — traded volume by day
13 Oct3L
12 Oct2L
9 Oct2L
8 Oct7L
7 Oct2L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SMS Pharmaceuticals Share Price
SMS Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

SMS Pharmaceuticals Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.